Difference between revisions of "Team:Tongji China/Judging form"

Latest revision as of 12:20, 17 October 2018

For Judges

Achievement

Judging Form

Bronze medal

Registration and Jamboree Attendance

We've successfully registered and will attend the Giant Jamboree.

Attributions

We have clear attributions. See more details at
https://2018.igem.org/Team:Tongji_China/Attributions

Characterization

We've successfully participated in the 2018 InterLab Study.
https://2018.igem.org/Team:Tongji_China/InterLab

Silver medal

Validated Part

We've made several new BioBricks relating to T3SS and cancer immunotherapy and successfully submitted them. The numbers of them are
https://2018.igem.org/Team:Tongji_China/Part

Collaboration

We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SKLMT-China and SJTU-BioX-Shanghai.
https://2018.igem.org/Team:Tongji_China/Collaborations

Human Practices

We’ve done education work in high school and some surveys according to our projects.
https://2018.igem.org/Team:Tongji_China/Human_Practices

Gold medal

Integrated Human Practices

We've done survey in range of society, hospitals and campus. According to the attitudes of the public and the advice from doctors and teachers, we've made further plans for our project. Besides, we've visited the Roche Co. and got the idea of our therapeutic product.
https://2018.igem.org/Team:Tongji_China/Human_Practices

Model Your Project

We've made a model of the antigen and SNVs.
https://2018.igem.org/Team:Tongji_China/Model

Demonstration of Your Work

We've done a series of experiments to make sure that the antigens can be transferred into APCs and thus trigger the immunoreaction.
https://2018.igem.org/Team:Tongji_China/Demonstrate

@@ Line 1: / Line 1: @@
 {{Tongji_China/Head_N_Prefix}}
-<html>
+{{Tongji_China/userDefault}}
- <link rel="stylesheet" type="text/css" href="https://2018.igem.org/Template:Tongji_China/userDefault?action=raw&ctype=text/css">
-</html>
 {{Tongji_China/Head_N_Suffix}}
 {{Tongji_China/Header_N}}
@@ Line 14: / Line 12: @@
 		<div class="background">
 <div class="content">
+<div class="title">Achievement</div>
+		<div class="logoPicture">
+			<img src="https://static.igem.org/mediawiki/2018/5/50/T--Tongji_China--picture-judgingform-0.png" width="15%" height="25%" />
+		</div>
+<div class="title_2">Judging Form</div>
 		<div class="judgeTitle" style="margin-top:auto;">
 			<br>Bronze medal
@@ Line 27: / Line 30: @@
 		</div>
 		<div class="content">
-			We have clear attributions.<br>
+			We have clear attributions. See more details at<br>
 			<a href="https://2018.igem.org/Team:Tongji_China/Attributions">https://2018.igem.org/Team:Tongji_China/Attributions</a><br><br>
 		</div>
@@ Line 44: / Line 47: @@
 		</div>
 		<div class="content">
-			We’ve made several new biobricks relating to T3SS and immunization therapy and successfully submitted them. The number of them are<br><br>
+			We've made several new BioBricks relating to T3SS and cancer immunotherapy and successfully submitted them. The numbers of them are<br>
+                        <a href="https://2018.igem.org/Team:Tongji_China/Part">https://2018.igem.org/Team:Tongji_China/Part</a><br><br>
 		</div>
 		<div class="judgeTitle2">
@@ Line 50: / Line 54: @@
 		</div>
 		<div class="content">
-			We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SDU-CHINA and SJTU-BioX-Shanghai.<br>
+			We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SKLMT-China and SJTU-BioX-Shanghai.<br>
 			<a href="https://2018.igem.org/Team:Tongji_China/Collaborations">https://2018.igem.org/Team:Tongji_China/Collaborations</a><br><br>
 		</div>
@@ Line 57: / Line 61: @@
 		</div>
 		<div class="content">
-			We’ve done education work in high school and do some survey according to our projects.<br>
+			We’ve done education work in high school and some surveys according to our projects.<br>
 			<a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a><br><br>
 		</div>
@@ Line 67: / Line 71: @@
 		</div>
 		<div class="content">
-			We’ve done survey both in society and in hospital and university. According to the attitude of the society and the advice of doctors and teachers, we made the further plan of our project. We’ve visited the Roche Co. and got the idea of our product.
+			We've done survey in range of society, hospitals and campus. According to the attitudes of the public and the advice from doctors and teachers, we've made further plans for our project. Besides, we've visited the Roche Co. and got the idea of our therapeutic product.
 			<br>
 			<a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a><br><br>
@@ Line 75: / Line 79: @@
 		</div>
 		<div class="content">
-			We’ve made the model of the antigen and SNVs.<br>
+			We've made a model of the antigen and SNVs.<br>
 			<a href="https://2018.igem.org/Team:Tongji_China/Model">https://2018.igem.org/Team:Tongji_China/Model</a><br><br>
 		</div>
@@ Line 82: / Line 86: @@
 		</div>
 		<div class="content">
-			We’ve done a series of experiments to make sure that the antigen can be transferred into APCs and will trigger the immunological reaction.<br>
+			We've done a series of experiments to make sure that the antigens can be transferred into APCs and thus trigger the immunoreaction.<br>
 			<a href="https://2018.igem.org/Team:Tongji_China/Demonstrate">https://2018.igem.org/Team:Tongji_China/Demonstrate</a><br><br>
 		</div>